Skip to main content

Research Repository

Advanced Search

Use of procalcitonin as a biomarker for sepsis in moderate to major paediatric burns

Holl�n, Linda; Hughes, Ryan; Dodds, Nick; Coy, Karen; Marlow, Karen; Pullan, Nicola; Davies, Julie; Dailami, Narges; Keating, Katrina; Falder, Sian; Shah, Mamta; Young, Amber

Authors

Linda Holl�n

Ryan Hughes

Nick Dodds

Karen Coy

Karen Marlow

Nicola Pullan

Julie Davies

Katrina Keating

Sian Falder

Mamta Shah

Amber Young



Abstract

Introduction: Accurate and early detection of sepsis poses a significant challenge in burn populations. Our objective was to assess whether procalcitonin is a marker of blood culture positive sepsis in moderate to severe paediatric burns. Methods: We analysed procalcitonin levels in 27 children admitted with burns of 15–65% total body surface area. Procalcitonin was measured at admission (baseline), 24 and 48 h post-admission and during periods of suspected sepsis (diagnosed against pre-defined criteria). Patients were categorised into controls with no episodes of suspected sepsis (n = 10) and those with episodes of suspected sepsis (n = 17). The latter were split into two groups based on blood culture results: culture positive (bacteraemia) and culture negative patients. Results: Baseline procalcitonin levels increased with burn size (odds ratio (95% confidence interval): 1.15 (1.02–1.29)). Suspected sepsis patients had larger burns than controls (median 31 vs. 20%; p = 0.003). Only 5/23 suspected sepsis episodes were blood culture positive. Procalcitonin levels were similar in culture positive and culture negative patients (p = 0.43). Sensitivity for predicting positive blood culture was 100% (95% confidence interval: 47.8–100.0%) but specificity was only 22.2% (95% confidence interval: 6.4–47.6%). Area under the curve was poor at 0.62 (95% confidence interval: 0.33–0.90). There was no significant change in procalcitonin levels from baseline to septic episode in either group (positive: p = 0.35; negative: p = 0.95). Conclusion: We conclude that evidence for the use of procalcitonin to diagnose bacteraemia in this population is poor, with burn size playing a significant role implying a correlation with systemic inflammation rather than sepsis.

Citation

Hollén, L., Hughes, R., Dodds, N., Coy, K., Marlow, K., Pullan, N., …Young, A. (2019). Use of procalcitonin as a biomarker for sepsis in moderate to major paediatric burns. Trauma, 21(3), 192-200. https://doi.org/10.1177/1460408618760940

Journal Article Type Article
Acceptance Date Feb 1, 2018
Online Publication Date Mar 27, 2018
Publication Date Jul 1, 2019
Deposit Date Sep 14, 2020
Journal Trauma (United Kingdom)
Print ISSN 1460-4086
Publisher SAGE Publications
Peer Reviewed Peer Reviewed
Volume 21
Issue 3
Pages 192-200
DOI https://doi.org/10.1177/1460408618760940
Keywords Procalcitonin, sepsis, burn injury, children, C-reactive protein
Public URL https://uwe-repository.worktribe.com/output/6675367